0 followers
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Industries
Headquarters
Stage
Employees
Links
9 members
4 members
2 members
MindMed
4 followers
BioMarin Pharmaceutical
21 followers
Adaptive Biotechnologies
11 followers
Agilent Technologies
60 followers
Regeneron
77 followers
Discover companies
